(PharmaNewsWire.Com, May 04, 2019 ) The "Global Self-injection Devices Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of self-injection devices market with detailed market segmentation by product, usage and geography. The global self-injection devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading self-injection devices market players and offers key trends and opportunities in the market.
Self-injection devices market is anticipated to grow in the forecast period owing to driving factors such as rising incidences of chronic diseases such as diabetes, rheumatoid arthritis, etc.; rising number of geriatric and diabetic population and rising awareness about self-injection systems. Self-injections allows the patient to inject drugs or medicines by themselves, which is the key factor fueling the growth of self-injection devices market. This ultimately gives an advantages such as low treatment cost, fewer visits to hospitals or clinics, and ease of use. Further, the extensive research and development activities by key major players in self-injection systems are expected to drive the global self-injection devices market.
Patients can inject multiple hormone or medicine in case of frequent dosage requirement for long term dosages patterns. Patients benefit from trustworthy and high accuracy of dosage through self-injecting systems. Self-injections are available in both reusable and disposable forms. Self-injections are widely used to inject growth hormones, insulin, biologic drugs for the treatment of chronic disease.
Leading Players:
1. Gerresheimer AG 2. Becton Dickinson 3. Amcor Limited 4. Schott AG 5. MeadWestvaco Corporation 6. AptarGroup, Inc. 7. Pfizer Inc. 8. Credence MedSystems, Inc. 9. West Pharmaceutical Services
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global self-injection devices market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The self-injection devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting self-injection devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Self-injection devices market in these regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
